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Abstract  
Introduction: Breast carcinoma originating from ectopic breast tissue (EBT) in men is a rare event. It may occur 
anywhere in the so-called milk line, with preference to the axilla, followed by the area immediately inferior to the 
normal breast. Additionally, it is presumed that EBT has an increased rate of malignant progression, when compared 
with normal breast tissue. In fact, benign and malignant tumors, such as epithelial, stromal or fibro-epithelial 
neoplasms, may arise from EBT.  
Presentation of Case: Here we describe a case of a 45-year old male who presented with a erythematous-brownish 
skin plaque located at his left groin. An incisional biopsy followed by a routine hematoxylin-eosin study revealed 
invasive neoplastic epithelial proliferation with obvious glandular differentiation extending from deep subcutaneous 
tissue to the superficial dermis. Lymphatic invasion was easily observed and the mitotic count was low (1 mitotic 
figure per square mm). Immunohistochemical staining showed neoplastic cells positive for estrogen receptor, 
progesterone receptor, gross cystic disease fluid protein 15 (GCDFP15) and mammaglobin, conforming a low-grade 
ductal infiltrating carcinoma (invasive mammary carcinoma of no special type).  
Conclusion: To our knowledge, this is the first report in the literature of a breast carcinoma originating from EBT in a 
male patient outside the thoracic region. Clinicians must be aware of EBT tumors to any lesion occurring in the milk 
line. 
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Introduction 
Ectopic breast tissue (EBT) is presumed to result from incomplete regression of the mammary 
ridges[1]. Moreover, EBT is not a common finding, with an incidence rate of 2.4% in neonates [2]. It 
may occur anywhere in the so-called milk line, with preference to the axilla, followed by the area 
immediately inferior to the normal breast. Comparing with orthotopic breast tissue, EBT usually 
responds to physiological stresses and hormonal stimulation in a similar way. Furthermore, benign and 
malignant tumors, such as epithelial, stromal or fibro-epithelial neoplasms, may arise from EBT [3-9].  
Breast carcinoma originating from EBT is an even rarer event. Although its true incidence is not 
clear[10], it is presumed to occur in 3.8% of EBT [11]. Some authors assume that EBT has an 
increased rate of malignant progression, when compared with normal breast tissue [10]. Here we 
describe a case of a low-grade ductal infiltrating carcinoma (invasive mammary carcinoma of no 
special type), arising from EBT located in the groin of a male patient. 
Case Presentation 
A 45-year-old male presented to a dermatologic consultation complaining of a 10-year history skin 
lesion located at the left iliac fossa. It started as a small papule and then progressed in the last year, 
when the patient noted erythema and induration of the lesion. No previous comorbidity was reported. 
On physical exam, an erythematous-brownish plaque measuring 2.0 x 3.0 cm was noted in the skin of 
his left groin. The lesion was irregular, with indistinct borders, central papillary projections and 
peripheral desquamation (Figure 1). 
 
 
 
Figure 1 Lesion as seen in physical exam: erythematous-brownish plaque, measuring 2,0 x 3,0 cm, with central 
papillary projections. 
 
Following the dermatologic consultation, an incisional biopsy was taken as the lesion was 
suspected to be neoplastic. Upon histologic evaluation of routine hematoxylin-eosin sections, an 
invasive neoplastic epithelial proliferation with obvious glandular differentiation was observed 
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extending from deep subcutaneous tissue to the superficial dermis. The proliferation consisted of 
haphazard arranged nests with solid, cribriform and acinar architecture with infiltrative borders (Figure 
2). On high power examination, neoplastic cells were monomorphic with pale cytoplasm and basally 
oriented regular nuclei with micronucleoli. The epidermis had an irregular papillary acanthosis 
correlated to the central papillary projections seen on physical exam. After examination of serial 
sections, a focus of invasion of the epidermis was identified (Figure 3). Lymphatic invasion was easily 
observed. The mitotic count was low (1 mitotic figure per square mm).    
 
 
 
 
 
Figure 2 Low magnification light 
microscopy (40x) showing haphazard 
glandular proliferation in dermis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 High magnification light 
microscopy (400x) showing cribriform 
glandular proliferation with low-grade 
nuclei. 
 
 
 
 
 
Immunohistochemical staining showed neoplastic cells positive for estrogen receptor (ER), 
progesterone receptor (PR), gross cystic disease fluid protein 15 (GCDFP15) and mammaglobin 
(Figure 4). Of note, cells were negative for HER2/neu, p63 and CK5. Pathology report of the 
incisional biopsy mentioned three hypotheses: (1) Primary breast carcinoma originating in EBT; (2) 
Metastatic breast carcinoma with primary site in orthotopic breast; (3) Primary skin adenocarcinoma.  
An extensive clinical and radiologic breast workup for primary tumors, including 
ultrasonography and magnetic resonance, was conducted and no tumor was found. An abdominal 
Ivy Union Publishing | http: //www.ivyunion.org June 3, 2016 | Volume 4, Issue 1 
Leal AI et al. American Journal of Cancer Case Reports 2016, 4:59-66
6
Page 4 of 8 
computed tomography shown no sign of metastatic visceral disease. A positron emission tomography 
computed tomography (PET-CT) showed a hipercaptant sign in the inguinal location of the lesion, 
associated with hypermetabolic inguinal left lymph node. Plasmatic tumor markers (CA15-3, CA19-9, 
and CEA) were within normal limits.  
 
 
 
 
 
Figure 4 Diffuse and strong 
positivity for mammaglobin 
(immunohistochemistry, 100X) 
 
 
 
 
 
 
 
 
 
 
 
A loco-regional surgery (R0 local excision with lymphadenectomy) was indicated. Surgical 
procedure was performed with no complications. Histopathologic examination demonstrated a residual 
tumor with similar morphologic and immunohistochemical features of the incisional biopsy. Surgical 
margins were free of tumor. Another skin lesion, located in left leg was also biopsied and reported as 
an unspecific dermatitis with lichenoid pattern. Resected inguinal lymph node showed a 
macrometastasis with involvement of perinodal soft tissue. Final histopathologic interpretation was of 
a ductal mammary carcinoma, histologic grade 1 (according to Nottingham classification), with lymph 
node metastasis and invasion of lymphatic and perineural spaces.  
After a multidisciplinary tumor board conference, an adjuvant chemotherapy regimen based on 
anthracycline and taxane was proposed. The patient received four cycles of AC (doxorubicin 60 
mg/m2, cyclophosphamide 600 mg/m2) followed by weekly paclitaxel (80 mg/m2) for 12 weeks. 
Considering the lymph draining areas were treated with lymphadenectomy, the patient was spared 
from radiation therapy, as it would increase rates of comorbidity, including lymphedema. Additionally, 
endocrine therapy with tamoxifen for five, up to 10 years, was also implemented. He is now in 
follow-up without evidence of disease recurrence. 
Discussion 
The exquisite final diagnosis of this case, initially presented as a skin tumor located in the groin of a 
male patient prompted the authors to write this brief manuscript. To our knowledge, this is the first 
report in the literature of a breast carcinoma originating from EBT in a male patient outside the 
thoracic region. Clinicians must be aware of EBT tumors to any lesion occurring in the milk line. Once 
identified, the ectopic tissue must be object of active surveillance in order to detect early neoplastic 
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alterations.  
Our case presents two clinicopathologic dilemmas: (1) to define whether the tumor is metastatic 
to, or, primary from the skin in the groin region; (2) to define if the lesion is originated from cutaneous 
appendages or from EBT. Patient’s ortotopic breasts were submitted to clinical and radiological 
examination, and no tumor was found. In addition, an uneventful follow-up (regarding eutopic breasts) 
makes the hypothesis of metastatic breast cancer an extremely remote possibility.  
In milk-line arising lesions, it has been much more difficult to define if the tumor is originated on 
breast tissue or cutaneous appendages, specially sweat glands. Breast and sweat glands share 
embryological, structural and functional features resulting in a striking resemblance to one another 
[12]. Both of them derive from ectodermal appendages, and although the mammary ducts arise from 
specialized mammary ridges, they are essentially comparable to modified sweat glands. Moreover, 
correlation of clinical, histologic and immunohistochemical features is required to make a precise 
definition whether a lesion is a breast carcinoma (BC) or a sweat gland carcinoma (SGC), such as 
cutaneous apocrine adenocarcinoma[13], hidradenocarcinoma, and eccrine porocarcinoma[3]. 
Furthermore, location and number of the neoplastic foci, history of malignancy, and duration of skin 
tumor have been stressed as important clinical diagnostic determinants[12]. The presence of normal 
breast tissue surrounding the tumor or compromised by carcinoma “in situ”[3] is a morphological 
evidence supporting the hypothesis of carcinoma arising from EBT[10]. In contrast, the presence of an 
epidermal connection would argue in favor of a primary adnexal neoplasm[14].  
Immunohistochemical assays have been used in a vast number of studies in order to differentiate 
BC from SGC [12, 14-17]. Essentially, these studies are underpowered because of the limited sample 
availability. This issue is even further complicated by the fact that BC and SGC are generic terms that 
cover a vast number of different tumors under the same name.  
Generally, SGCs lesions are positive for basal cell markers (p63 and CK5/6). In contrast, BCs 
should be negative for them. Mentrikoski et al. demonstrated that the sensitivity and specificity for 
p63 in distinguishing BC from SGC is 81% and 94%, respectively [12]. However, not all BC will be 
negative for basal markers. The well-known basal-like breast cancers are known to express basal 
cytokeratin and p63. Fortunelly, basal-like breast cancers are either of a special histologic subtype or 
have a high grade sarcomatoid phenotype, and should not be confused with the low grade, ductal 
phenotype of SGC. In our case, the low-grade ductal morphology, in association with lack of 
expression of basal cytokeratin and p63, is a strong evidence of mammary differentiation. Also, 
GCDFP15 and mammaglobin are used to identify breast origin of carcinomas in metastatic setting[18]. 
Unfortunelly sensitivity and specificity of GCDFP15 in sorting BC from SGC have been low in some 
observations[17, 19, 20]. On the order hand, mammaglobin has been expressed in two-thirds of BC 
and has been negative in SGS, as reported by Rollins-Raval et al.[17]. In another series, mammaglobin 
was observed in one case of SGC, and the sensibility and specificity was 45% and 95%, respectively 
[12]. The expression of mammaglobin in the case presented here was interpreted as another strong 
evidence to support the breast differentiation for the neoplasia. 
Hormonal receptors are routinely used for the identification of breast carcinoma in metastatic 
setting, as the majority of BCs express ER and PR. However, SGC also express these proteins [20-22]. 
Therefore, they are not helpful in differentiating BC and SGC as both lesions express hormonal 
receptors. Moreover, GATA3, a transcription factor involved in embryologic development of the 
mammary glands, is also of no use in this clinical setting[12].    
Embriologically, breast tissue derives from the mammary ridges, which undergo septation to form 
mammary buds, the precursors of mature breasts. A theory, once universally accepted, states that 
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mammary ridges extend from the axilla to the inguinal regions (the so-called milk line), and that the 
incomplete regression of mammary ridges may be the origin of EBT. This concept is influenced by a 
blend of phylogenetic and ontogenetic embryological theories. In fact, human breast development, in 
early literature, was compared with cetaceans (e.g. whales and dolphins) breast development, which 
have breasts localized to the caudal perigenital region[23]. Regarding specifically breast-like tissue in 
anogenital regions, van der Putte[24] challenged this theory since it has not been supported by 
observations in human embryos, which show that primordia of the mammary glands do not extend 
beyond the axillary-pectoral area. The phenomenon of breast-like tissue and lesions in anogenital 
regions was then reevaluated, and resulted in the proposal of mammary-like anogenital glands (MLG) 
theory. These glands were assumed being a normal constituent of the vulva, and are a distinct type of 
cutaneous glandular unit present in the anogenital region, sharing features of eccrine, apocrine and 
mammary glands. Later, van der Putte postulated that mammary-type lesions of the vulva and 
perineum arise from these structures rather than from ectopic breast tissue[24]. This theory was 
subsequently accepted and served as basis for nomenclature in vulvar mammary-like lesions[3-9, 
23-25].    
It is beyond the scope of this brief report to elucidate the subject whether the mammary line 
theory or the MLG give rise to breast tissue outside the axillary-pectoral area. However, the 
occurrence of a mammary-like carcinoma occurring in the groin of a male patient as described herein 
should put both theories in debate again. 
Conclusion 
In summary, we report a case of a low-grade infiltrating carcinoma with ductal phenotype, expressing 
mammaglobin and lacking the expression of p63 and basal cytokeratins, thus interpreted as a breast 
carcinoma arising from EBT in the groin of a male patient. Lesions occurring underneath the 
mammary line should raise suspicion for dermatologists and pathologists, as they might be related to 
breast tissue development.   
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